MEDX
MEDX 2-star rating from Upturn Advisory

Horizon Kinetics Medical ETF (MEDX)

Horizon Kinetics Medical ETF (MEDX) 2-star rating from Upturn Advisory
$33.45
Last Close (24-hour delay)
Profit since last BUY24.95%
upturn advisory logo
Consider higher Upturn Star rating
BUY since 148 days
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

01/09/2026: MEDX (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

Upturn 2 star rating for performance

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type ETF
Historic Profit 31.85%
Avg. Invested days 74
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
ETF Returns Performance Upturn Returns Performance icon 5.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 01/09/2026
Advertisement

Key Highlights

Volume (30-day avg) -
Beta 0.49
52 Weeks Range 23.46 - 31.41
Updated Date 06/30/2025
52 Weeks Range 23.46 - 31.41
Updated Date 06/30/2025
Advertisement

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Horizon Kinetics Medical ETF

Horizon Kinetics Medical ETF(MEDX) company logo displayed in Upturn AI summary

ETF Overview

overview logo Overview

The Horizon Kinetics Medical ETF (MEDX) is an actively managed exchange-traded fund focused on identifying and investing in companies within the healthcare sector that are poised for significant growth. The fund's strategy centers on identifying companies with innovative products, services, or technologies that address unmet medical needs or offer substantial improvements over existing solutions. Its asset allocation is primarily concentrated in equities, with a particular emphasis on small- and mid-cap companies that may offer higher growth potential but also carry increased risk.

Reputation and Reliability logo Reputation and Reliability

Horizon Kinetics is an investment advisor focused on identifying and investing in companies with differentiated business models and significant growth potential. While not a massive issuer by AUM compared to giants like Vanguard or BlackRock, it has a dedicated following among investors seeking actively managed, concentrated strategies.

Leadership icon representing strong management expertise and executive team Management Expertise

The ETF is managed by Horizon Kinetics LLC, a firm known for its fundamental research-driven approach to identifying unique investment opportunities. The management team typically emphasizes deep dives into company operations, competitive landscapes, and disruptive potential within their respective industries.

Investment Objective

Icon representing investment goals and financial objectives Goal

The primary investment goal of the Horizon Kinetics Medical ETF is to achieve long-term capital appreciation by investing in a concentrated portfolio of companies operating in the medical field.

Investment Approach and Strategy

Strategy: This ETF does not aim to track a specific index. Instead, it employs an active management strategy, where the portfolio managers conduct in-depth fundamental research to select individual securities they believe will outperform.

Composition The ETF is primarily composed of equities, focusing on companies within the biotechnology, pharmaceutical, medical devices, and healthcare services sub-sectors. The portfolio is typically concentrated, meaning it holds a relatively smaller number of carefully selected stocks.

Market Position

Market Share: Data on the specific market share of the Horizon Kinetics Medical ETF within the broader healthcare ETF market is not readily available and can fluctuate. Its market share is likely small compared to broad-market healthcare ETFs.

Total Net Assets (AUM): As of recent data, the Total Net Assets (AUM) for the Horizon Kinetics Medical ETF typically range in the tens to low hundreds of millions of US dollars, indicating a niche market position.

Competitors

Key Competitors logo Key Competitors

  • iShares U.S. Healthcare ETF (IYH)
  • Health Care Select Sector SPDR Fund (XLV)
  • Vanguard Health Care ETF (VHT)

Competitive Landscape

The US healthcare ETF market is highly competitive and dominated by large, passively managed index funds like XLV and VHT, which offer broad diversification and low expense ratios. MEDX operates in a niche with its actively managed, concentrated approach, appealing to investors seeking potentially higher alpha but with higher risk and potentially higher fees. Its advantage lies in its focused strategy and potential for manager skill to drive outperformance, while its disadvantage is its lack of broad diversification and the inherent risks of active management and concentration.

Financial Performance

Historical Performance: Historical performance data for MEDX shows variable returns, influenced by its concentrated and actively managed nature. Investors should review the ETF's performance over various timeframes (1-year, 3-year, 5-year, inception-to-date) to understand its track record, noting periods of both outperformance and underperformance relative to broader healthcare indices.

Benchmark Comparison: As an actively managed fund, MEDX's performance is benchmarked against broader healthcare indices, though its concentrated holdings may lead to significant divergence. Comparisons should be made against relevant healthcare benchmarks to assess the manager's ability to add value.

Expense Ratio: The expense ratio for the Horizon Kinetics Medical ETF is typically higher than passive index ETFs, reflecting the costs associated with active management. This is usually in the range of 0.70% to 1.00%.

Liquidity

Average Trading Volume

The ETF's average trading volume can vary, but it is generally lower than that of the largest healthcare ETFs, indicating moderate liquidity.

Bid-Ask Spread

The bid-ask spread for MEDX can be wider than that of highly liquid ETFs, meaning there might be a slightly higher cost associated with frequent trading.

Market Dynamics

Market Environment Factors

The ETF is influenced by broad economic conditions, regulatory changes impacting the healthcare industry, advancements in medical technology, patent expirations, and shifts in healthcare policy. Growth prospects are tied to innovation and demand for healthcare services and products.

Growth Trajectory

The growth trajectory of MEDX is dependent on the success of its specific stock selections and the overall performance of the healthcare sector. Changes in strategy would involve adjustments to its holdings based on evolving market conditions and the manager's outlook on individual companies.

Moat and Competitive Advantages

Competitive Edge

MEDX's competitive edge lies in its active management and concentrated approach, seeking to exploit inefficiencies and undiscovered growth opportunities within the medical sector. The managers aim to identify companies with disruptive technologies or strong competitive moats in their specific niches. This focused strategy allows for potentially higher alpha generation compared to broad-market index funds, by hand-picking promising, under-the-radar medical innovators.

Risk Analysis

Volatility

The historical volatility of MEDX is likely to be higher than broad-market healthcare ETFs due to its concentrated portfolio and focus on smaller-cap, growth-oriented companies. These companies can experience more significant price swings.

Market Risk

Specific market risks include regulatory changes affecting drug approvals or healthcare services, patent cliff events, competition from generic alternatives, and shifts in investor sentiment towards growth stocks. The concentrated nature of the portfolio means that the poor performance of a few key holdings could significantly impact overall returns.

Investor Profile

Ideal Investor Profile

The ideal investor for MEDX is an individual seeking long-term capital appreciation, comfortable with higher risk and volatility, and who believes in the potential of actively managed strategies in the healthcare sector. They should have a strong understanding of the medical industry and the specific investment thesis of the fund.

Market Risk

MEDX is generally best suited for long-term investors who are looking for concentrated exposure to high-growth medical companies and are willing to accept the risks associated with active management and a less diversified portfolio. It is not typically recommended for short-term traders or those seeking broad, passive market exposure.

Summary

The Horizon Kinetics Medical ETF (MEDX) is an actively managed fund focusing on high-growth medical companies. It seeks long-term capital appreciation through a concentrated portfolio of innovative healthcare stocks. While offering potential for alpha generation, it carries higher risk and volatility compared to passive healthcare ETFs due to its active management and concentrated holdings. Its expense ratio is also higher than index-tracking alternatives. MEDX is best suited for risk-tolerant, long-term investors with a conviction in the fund's active management strategy within the dynamic healthcare sector.

Similar ETFs

Sources and Disclaimers

Data Sources:

  • Horizon Kinetics Official Website (Hypothetical - actual data requires live access)
  • Financial Data Providers (e.g., Morningstar, ETF Database, Bloomberg - Hypothetical)
  • SEC Filings (Hypothetical)

Disclaimers:

This information is for illustrative purposes only and should not be considered investment advice. ETF performance can vary, and past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a financial advisor before making investment decisions. Market share data and competitor information are estimates and subject to change.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Horizon Kinetics Medical ETF

Exchange NASDAQ
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The fund is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.